Medical News

RSS

New photo-responsive nanomedicine for light-controlled colorectal cancer therapy

A research team from Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong (HKUMed), has developed a photo-responsive nanomedicine for light-controlled colorectal cancer therapy.

21 Apr 2022

Study highlights mortality risk and healthcare utilization of people with treatment-resistant depression

Researchers from the Department of Pharmacology and Pharmacy, Department of Medicine, Department of Pediatrics and Adolescent Medicine of the LKS Faculty of Medicine, The University of Hong Kong (HKUMed) and Department of Social Work and Social Administration at The University of Hong Kong (HKU).

21 Apr 2022

Using CR2Crry to reduce the negative effects of brain hemorrhaging in premature infants

A little over 1% of babies born in the U.S. in 2020 fell under the category of very low birthweight, meaning they weighed less than 1,500 grams at birth or 3 pounds, 4 ounces. And considering that the Centers for Disease Control and Prevention says more than 3.5 million babies were born that year, almost 48,500 were considered to be at very low birthweight.

21 Apr 2022

Researchers test an experimental treatment for metastatic cancer

Researchers at the University of Oklahoma are testing an experimental treatment for metastatic cancer focusing on pancreatic cancer.

20 Apr 2022

Revolutionary mRNA vaccine technology: History, facts and the future

mRNA vaccine technology is a field full of promise – as well as unanswered questions – for communities living with the burden of the world’s most deadly infectious diseases.

20 Apr 2022

DNA abnormality explains insensitivity to chemotherapy in germ cell cancer

Extra copies of a piece of DNA partly explain insensitivity to chemotherapy in germ cell cancer, a new study shows.

20 Apr 2022

CDC announces two COVID-19 travel-related updates based on current scenario

Today, CDC is announcing two COVID-19 travel-related updates based on close-monitoring of the COVID-19 landscape in the United States and internationally.

20 Apr 2022

Natural immunity provides a longer window of protection against COVID-19 infection than mRNA vaccines

A study released in JAMA Network Open by investigators at Providence, one of the largest health systems in the United States, and the University of Chicago, found that the level of protection granted by a prior symptomatic COVID-19 infection among unvaccinated individuals was on par with the level of protection provided by mRNA vaccines, with natural immunity providing a longer window of protection than mRNA vaccines.

20 Apr 2022

RNA splicing abnormalities in COVID-19 patients

This study entailed the integration of multiple-omics datasets to examine the dysregulation in the host splicing mechanism and alteration in protein isoforms among COVID-19 patients.

20 Apr 2022

New insight into SARS-CoV-2 main protease opens door to new viral inhibitors

A recent study has revealed a full cycle of substrate cleavage for the main protease of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – providing, in turn, a steadfast foundation for developing potent new viral inhibitors. The paper was published in the journal Proceedings of the National Academy of Sciences (PNAS).

20 Apr 2022

Geoengineering the climate could redistribute malaria risk in tropical countries

Geoengineering the climate would have massive repercussions for the health of billions of people at risk of malaria who live in tropical countries, according to a new finding by scientists at Georgetown University Medical Center and colleagues.

20 Apr 2022

Portable MRIs enable highly accessible and bedside detection of ischemic stroke

Portable MRI machines, an emerging technology that makes medical imaging accessible even in remote locations, detected ischemic strokes, or strokes caused by clotting, in 90% of patients scanned, according to a study led by Yale and Harvard researchers.

20 Apr 2022

Study examines vitamin D and COVID-19 media coverage in the U.K.

A new study investigates the relationship between COVID-19 and vitamin D that has been presented in traditional media sources like U.K. newspapers.

20 Apr 2022

Opioid-related mortality rising among younger adults, study reveals

From 2003 through 2020, as opioid-related mortality in Ontario, Canada increased five-fold, the age distribution also shifted downward – with rates now peaking for people in their mid-30s – according to a new study published this week in the open-access journal PLOS ONE by Patrick Brown of University of Toronto, and colleagues.

20 Apr 2022

Advancements in HIV science

As far as viruses go, human immunodeficiency virus (HIV) is quite simple. About 100,000 times smaller than a red blood cell, the virus expresses just a dozen proteins, yet it can establish a lifelong infection that, if left untreated, causes acquired immunodeficiency syndrome (AIDS) and death.

20 Apr 2022

Antibody response to Pfizer-BioNTech COVID-19 vaccine over 6 months

A new study published in PLoS ONE characterizes the antibody response to BNT162b2, the Pfizer-BioNTech COVID-19 vaccine

20 Apr 2022

Researchers discover more needles in the haystack in the quest to unravel Alzheimer’s disease

21 million. That's the number of genetic variations in the human genome that researchers are sifting to identify patterns predisposing people to Alzheimer's disease.

20 Apr 2022

Novel saliva immunoassays to detect prior SARS-CoV-2 infection

Six salivary ELISAs were developed to evaluate the immune response to SARS-CoV-2 and estimate rates of past infection.

20 Apr 2022

Eliminating harmful noise from ventilation system fans could help improve health

We spend more of our time indoors than ever. But the noise levels we are exposed to at home, in workplaces and schools have been shown to increase the risk of high blood pressure, mental illness and hearing damage - and may even have a detrimental effect on children's cognitive development.

20 Apr 2022

Radioconjugates could transform the future of cancer care

Many current cancer treatments make patients very sick because even the most targeted treatments kill healthy cells as well as cancer cells. But a new type of treatment called a radioconjugate is getting the attention of oncologists.

20 Apr 2022

Medical News

New photo-responsive nanomedicine for light-controlled colorectal cancer therapy

Study highlights mortality risk and healthcare utilization of people with treatment-resistant depression

Using CR2Crry to reduce the negative effects of brain hemorrhaging in premature infants

Researchers test an experimental treatment for metastatic cancer

Revolutionary mRNA vaccine technology: History, facts and the future

DNA abnormality explains insensitivity to chemotherapy in germ cell cancer

CDC announces two COVID-19 travel-related updates based on current scenario

Natural immunity provides a longer window of protection against COVID-19 infection than mRNA vaccines

RNA splicing abnormalities in COVID-19 patients

New insight into SARS-CoV-2 main protease opens door to new viral inhibitors

Geoengineering the climate could redistribute malaria risk in tropical countries

Portable MRIs enable highly accessible and bedside detection of ischemic stroke

Study examines vitamin D and COVID-19 media coverage in the U.K.

Opioid-related mortality rising among younger adults, study reveals

Advancements in HIV science

Antibody response to Pfizer-BioNTech COVID-19 vaccine over 6 months

Researchers discover more needles in the haystack in the quest to unravel Alzheimer’s disease

Novel saliva immunoassays to detect prior SARS-CoV-2 infection

Eliminating harmful noise from ventilation system fans could help improve health

Radioconjugates could transform the future of cancer care

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News